Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05816733Phase 4Unknown

Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure

Role: lead

NCT05888168Unknown

Predictors of Postoperative Atrial Fibrillation After CABG

Role: lead

NCT05374655Not ApplicableUnknown

Outcomes Study of Glycosylated Hemoglobin Control in Cox-Maze IV During Cardiac Surgery

Role: lead

NCT05600010Unknown

Detection of Microplastics in Cardiac Surgery Patients

Role: lead

All 4 trials loaded